Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care
The relationship existing between heart failure (HF) and COVID-19 remains questioned and poorly elucidated. Many reports suggest that HF events are reduced during pandemics, although other studies have demonstrated higher mortality and sudden death in patients affected by HF. Several vascular, throm...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/11/3/790 |
| _version_ | 1827751175937589248 |
|---|---|
| author | Alberto Palazzuoli Matteo Beltrami Peter A. McCullough |
| author_facet | Alberto Palazzuoli Matteo Beltrami Peter A. McCullough |
| author_sort | Alberto Palazzuoli |
| collection | DOAJ |
| description | The relationship existing between heart failure (HF) and COVID-19 remains questioned and poorly elucidated. Many reports suggest that HF events are reduced during pandemics, although other studies have demonstrated higher mortality and sudden death in patients affected by HF. Several vascular, thrombotic, and respiratory features may deteriorate stable HF patients; therefore, the infection may directly cause direct myocardial damage, leading to cardiac function deterioration. Another concern is related to the possibility that antiviral, anti-inflammatory, and corticosteroid agents commonly employed during acute COVID-19 infection may have potentially deleterious effects on the cardiovascular (CV) system. For these reasons, HF patients deserve specific management with a tailored approach in order to avoid arrhythmic complications and fluid retention events. In this review, we describe the complex interplay between COVID-19 and HF, the evolving trend of infection with related CV events, and the specific management strategy to adopt in this setting. |
| first_indexed | 2024-03-11T06:53:37Z |
| format | Article |
| id | doaj.art-7e0a6145d0254e57bdd180d906caf509 |
| institution | Directory Open Access Journal |
| issn | 2227-9059 |
| language | English |
| last_indexed | 2024-03-11T06:53:37Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj.art-7e0a6145d0254e57bdd180d906caf5092023-11-17T09:45:39ZengMDPI AGBiomedicines2227-90592023-03-0111379010.3390/biomedicines11030790Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital CareAlberto Palazzuoli0Matteo Beltrami1Peter A. McCullough2Cardiovascular Diseases Unit, Department of Medical Sciences, Le Scotte Hospital University of Siena Italy, 53100 Siena, ItalyCardiology Unit, San Giovanni di Dio Hospital, Azienda USL Toscana Centro, 50134 Florence, ItalyTruth for Health Foundation, Tucson, AZ 85728, USAThe relationship existing between heart failure (HF) and COVID-19 remains questioned and poorly elucidated. Many reports suggest that HF events are reduced during pandemics, although other studies have demonstrated higher mortality and sudden death in patients affected by HF. Several vascular, thrombotic, and respiratory features may deteriorate stable HF patients; therefore, the infection may directly cause direct myocardial damage, leading to cardiac function deterioration. Another concern is related to the possibility that antiviral, anti-inflammatory, and corticosteroid agents commonly employed during acute COVID-19 infection may have potentially deleterious effects on the cardiovascular (CV) system. For these reasons, HF patients deserve specific management with a tailored approach in order to avoid arrhythmic complications and fluid retention events. In this review, we describe the complex interplay between COVID-19 and HF, the evolving trend of infection with related CV events, and the specific management strategy to adopt in this setting.https://www.mdpi.com/2227-9059/11/3/790heart failureCOVID-19treatmentcardiovascular events |
| spellingShingle | Alberto Palazzuoli Matteo Beltrami Peter A. McCullough Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care Biomedicines heart failure COVID-19 treatment cardiovascular events |
| title | Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care |
| title_full | Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care |
| title_fullStr | Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care |
| title_full_unstemmed | Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care |
| title_short | Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care |
| title_sort | acute covid 19 management in heart failure patients a specific setting requiring detailed inpatient and outpatient hospital care |
| topic | heart failure COVID-19 treatment cardiovascular events |
| url | https://www.mdpi.com/2227-9059/11/3/790 |
| work_keys_str_mv | AT albertopalazzuoli acutecovid19managementinheartfailurepatientsaspecificsettingrequiringdetailedinpatientandoutpatienthospitalcare AT matteobeltrami acutecovid19managementinheartfailurepatientsaspecificsettingrequiringdetailedinpatientandoutpatienthospitalcare AT peteramccullough acutecovid19managementinheartfailurepatientsaspecificsettingrequiringdetailedinpatientandoutpatienthospitalcare |